Blue Horizon International(BHI), Alpha Blu Skin Care, BHI Therapeutic Sciences, and BHI Rejuvenation participated in the 24th World Congress on Anti-Aging Medicine & Exhibition in Las Vegas, December 9-11, 2016. BHI’s skin care line, Alpha Blu Skin Care was available for purchase. [...]

Regenerative therapy with Stem Cell has become a more frequent treatment for orthopedic conditions in the US, including knee, hip and shoulder osteoarthritic pain. For those patients with joint pain, the current steps of treatment in U.S. include first, activity [...]

American orthopedic surgeon, internationally recognized stem cell researcher and founder of Mehling Orthopedics and chief medical officer of Blue Horizon International (BHI), Brian Mehling, M.D., spoke at the Fifth Annual Tissue Engineering and Regenerative Medicine. The conference was held September [...]

American orthopedic surgeon and internationally recognized stem cell researcher, founder of Mehling Orthopedics, and chief medical officer of Blue Horizon International (BHI), Brian Mehling, M.D., is set to present at the 2nd European Congress of Hockey Medicine from June 2-4 [...]

American orthopedic surgeon, internationally recognized stem cell researcher and founder of Mehling Orthopedics and chief medical officer of Blue Horizon International (BHI), Brian Mehling, M.D., spoke at the seventh Annual Conference on Stem Cells and Regenerative Medicine. The conference was [...]

Blue Horizon International’s cellular and regenerative medicine program at Malacky Hospital, Slovakia’s first and only treatment facility, celebrated the treatment of its 100th patient. Located in the western part of Slovakia, just under an hour’s drive from Vienna International Airport, [...]

American orthopedic surgeon and internationally recognized stem cell researcher, founder of Mehling Orthopedics and chief medical officer of Blue Horizon International (BHI), Brian Mehling, M.D., spoke at an International Conference and Expo on Musculoskeletal Disease and Regeneration. The conference was [...]

Brian Mehling, M.D. addresses developments in stem cell research Brian Mehling, M.D., CMO of Blue Horizon International was a featured speaker at a joint annual meeting sponsored by IsraStem and ISCS (Israel Stem Cell Society). Dr. Mehling spoke on the [...]

John Ferguson, MBA and Doreen Santora, R.N., traveled to Bratislava and Malacky, Slovakia to meet with leadership, physicians and patients.     NEW YORK, March 23, 2016 /PRNewswire/ — Blue Horizon International’s executive leadership, John Ferguson, MBA and Doreen Santora, R.N., [...]

Brian Mehling, M.D., a board-certified orthopedic surgeon and CMO of Blue Horizon International, presented his study on clinical applications of mesenchymal stem cells   NEW YORK, March 23, 2016 /PRNewswire/ — Internationally recognized stem cell researcher and chief medical officer [...]